Literature DB >> 23250479

Intravitreal bevacizumab for iris tumor metastasized from large cell neuroendocrine carcinoma of lung.

Hirotaka Yokouchi1, Masayasu Kitahashi, Toshiyuki Oshitari, Shuichi Yamamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23250479     DOI： 10.1007/s00417-012-2218-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  7 in total

1.  Intravitreal bevacizumab for iris metastasis of small-cell lung carcinoma with neovascular glaucoma.

Authors:  Chikae Nakashima; Hiroshi Keino; Takayo Watanabe; Wakako Taki; Annabelle A Okada
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

2.  Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.

Authors:  S X Jiang; T Kameya; M Shoji; Y Dobashi; J Shinada; H Yoshimura
Journal:  Am J Surg Pathol       Date:  1998-05       Impact factor: 6.394

3.  Clinical survey of 3680 iris tumors based on patient age at presentation.

Authors:  Carol L Shields; Swarupa Kancherla; Jinali Patel; Priya Vijayvargiya; Mayerling M Suriano; Emily Kolbus; Ami Badami; Priya Sharma; Emily Jacobs; Matt Voluck; Zina Zhang; Rishav Kansal; Patrick W Shields; Carlos G Bianciotto; Jerry A Shields
Journal:  Ophthalmology       Date:  2011-10-27       Impact factor: 12.079

Review 4.  Large-cell neuroendocrine carcinoma of the lung: an aggressive neuroendocrine lung cancer.

Authors:  Felix G Fernandez; Richard J Battafarano
Journal:  Semin Thorac Cardiovasc Surg       Date:  2006

5.  Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.

Authors:  W D Travis; R I Linnoila; M G Tsokos; C L Hitchcock; G B Cutler; L Nieman; G Chrousos; H Pass; J Doppman
Journal:  Am J Surg Pathol       Date:  1991-06       Impact factor: 6.394

6.  Metastatic tumors to the iris in 40 patients.

Authors:  J A Shields; C L Shields; H Kiratli; P de Potter
Journal:  Am J Ophthalmol       Date:  1995-04       Impact factor: 5.258

7.  Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma.

Authors:  Kenzo Hiroshima; Akira Iyoda; Kiyoshi Shibuya; Yukiko Haga; Tetsuya Toyozaki; Toshihiko Iizasa; Toshinori Nakayama; Takehiko Fujisawa; Hidemi Ohwada
Journal:  Cancer       Date:  2004-03-15       Impact factor: 6.860
  7 in total
  6 in total

Review 1.  Treatment of lung large cell neuroendocrine carcinoma.

Authors:  Giuseppe Lo Russo; Sara Pusceddu; Claudia Proto; Marianna Macerelli; Diego Signorelli; Milena Vitali; Monica Ganzinelli; Rosaria Gallucci; Nicoletta Zilembo; Marco Platania; Roberto Buzzoni; Filippo de Braud; Marina Chiara Garassino
Journal:  Tumour Biol       Date:  2016-03-04

2.  Peripapillary Neuroendocrine Carcinoma Metastasis: A Novel Approach to Treatment.

Authors:  Colin S Ip; Yuval Raizen; David Goldfarb; Eric Kegley; Jose Munoz; Amy C Schefler
Journal:  Ocul Oncol Pathol       Date:  2021-06-02

Review 3.  Treatment options for patients with large cell neuroendocrine carcinoma of the lung.

Authors:  Akira Iyoda; Takashi Makino; Satoshi Koezuka; Hajime Otsuka; Yoshinobu Hata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-04-10

4.  Iris metastasis as the first sign of small cell lung cancer: A case report.

Authors:  Shi-Liang Liu; Yu-Hong Nie; Tao He; Xi-Xi Yan; Yi-Qiao Xing
Journal:  Oncol Lett       Date:  2017-01-25       Impact factor: 2.967

Review 5.  [Ocular Metastasis in Lung Cancer: a Retrospective Analysis in a Single Chinese Hospital and Literature Review].

Authors:  Yan Xu; Yiduo Sun; Jing Zhao; Minjiang Chen; Lina Jiangde; Longyun Li; Wei Zhong; Mengzhao Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-05-20

6.  Primary neuroendocrine carcinoma of ocular adnexa.

Authors:  Daisuke Yamanouchi; Toshiyuki Oshitari; Yosuke Nakamura; Jiro Yotsukura; Kaoru Asanagi; Takayuki Baba; Tomohiro Nizawa; Takashi Kishimoto; Yoko Yonemori; Satoshi Ota; Shuichi Yamamoto
Journal:  Case Rep Ophthalmol Med       Date:  2013-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.